Patterns, Predictors, and Prognostic Implication of Treatment-Related Amenorrhea in Patients With Breast Cancer [0.03%]
乳腺癌患者与治疗相关的闭经的模式，预测和预后意义
Bryant Ng,Armeyra Devani Ferintasari,Susanna Hilda Hutajulu et al.
Bryant Ng et al.
Background: Treatment-related amenorrhea (TRA) is a common side effect of treatment in premenopausal patients with breast cancer, with important consequences for patient counseling and management. Its occurrence and poten...
Tumor Necrosis Factor-Alpha and Its Association With Breast Cancer: A Systematic Review [0.03%]
肿瘤坏死因子-α及其与乳腺癌的关联：系统评价
Nur Qodir,Didit Pramudhito;Legiran;Zen Hafy,Muhammad Baharul Iman et al.
Nur Qodir et al.
Background: Tumor necrosis factor-alpha (TNF-α) is a pro-inflammatory cytokine implicated in the pathogenesis and progression of various cancers, including breast cancer. Elevated TNF-α levels have been associated with ...
Should All Low-Grade Ductal Carcinoma In Situ Be Excised? Implications and Challenges of the COMET Trial [0.03%]
是否所有低级别的导管原位癌均需切除？COMET试验的启示与挑战
Hiroki Kusama,Yoshiya Horimoto,Kazuaki Takabe et al.
Hiroki Kusama et al.
CD19 Expression in B-Cell Lymphomas and Clinical Considerations in the Evolving Landscape of CD19-Targeted Therapy [0.03%]
B细胞淋巴瘤中的CD19表达及针对CD19的治疗前景中的临床考虑事项
Joseph P Marshalek,Xin Qing,Sarah Tomassetti
Joseph P Marshalek
Time to Treatment Initiation of Lung, Breast, Colorectal, and Prostate Cancers and Contributing Factors From 2015 to 2020 Utilizing Surveillance, Epidemiology, and End Results Program Database [0.03%]
2015至2020年利用监测、流行病学和最终结果程序数据库分析肺癌、乳腺癌、结直肠癌和前列腺癌的治疗开始时间及影响因素
Mariela Di Vanna,Shreya Shambhavi,Murod Khikmatov et al.
Mariela Di Vanna et al.
Background: The aim of the study was to identify the factors that cause delays in treatment initiation, such as race, gender, education, income status, and associated health comorbidities, as these can increase mortality....
Kyla Wright,Michael A Mederos,Irene R Riahi et al.
Kyla Wright et al.
Malignant biliary obstruction can, in rare cases, arise from metastases to the biliary tree from distant primary tumors. This phenomenon often poses a diagnostic challenge, as bile duct metastases may clinically and radiologically mimic pri...
Case Reports
World journal of oncology. 2025 Apr;16(2):227-234. DOI:10.14740/wjon2008 2025
Talal S Al-Qaisi,Berjas Abumsimir,Maher Sughayer et al.
Talal S Al-Qaisi et al.
Background: In Jordan, lung cancer ranks as the second most common tumor, and there is an urgent need to explore the genetic landscape of lung cancer. This study aimed to identify the actionable mutations in lung cancer s...
Comprehensive Investigation of a Tyrosine Kinase Inhibitor-Resistant Gene Zeste White 10 in Hepatocellular Carcinoma [0.03%]
酪氨酸激酶抑制剂耐药基因Zeste白10在肝细胞癌中的综合研究
Qing Ling Huang,Guan Lan Zhang,Qin Yan Su et al.
Qing Ling Huang et al.
Background: Tyrosine kinase inhibitors (TKIs) are first-line therapies for hepatocellular carcinoma (HCC), but the drug resistance restricts the long-term clinical outcomes. This study aimed to investigate the expression ...
Prevalence and Clinical Outcomes of Human Epidermal Growth Factor Receptor 2 Expression in Patients With Advanced Urothelial Carcinoma [0.03%]
晚期尿路上皮癌患者的人表皮生长因子受体2表达的流行病学特征及其临床预后研究
Ivan A Ortiz-Calderon,Luis Felipe Arias-Ruiz,Rita Dorantes-Heredia et al.
Ivan A Ortiz-Calderon et al.
Background: The prognosis for urothelial carcinoma remains poor, with limited therapeutic options, emphasizing the need for further research into targeted therapies. The prognostic and predictive significance of human epi...
Survival Analysis of Anaplastic Thyroid Carcinoma With Various Therapeutic Modalities: Twenty-Seven Years' Experience in a Single Cancer Center [0.03%]
单一癌症中心27年不同治疗方式下间变性甲状腺癌的生存分析经验总结
Putu Anda Tusta Adiputra,I Gede Budhi Setiawan,I Putu Gede Septiawan Saputra et al.
Putu Anda Tusta Adiputra et al.
Background: Anaplastic thyroid carcinoma (ATC) is the most aggressive thyroid gland malignancy. Several consensuses support the concept of multimodal therapy that combines surgery, radiation, chemotherapy, and targeted th...